SCHEMBL3149037

SCHEMBL3149037

O=C1Nc2cc(C(=O)O)ccc2C1=C(Nc1ccc(CN2CCCCC2)cc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.48
HTT P42858 2/20 0.48
RAB9A P51151 1/20 0.48
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
HIF1A Q16665 1/20 0.47
TNF P01375 1/20 0.45
LTA4H P09960 2/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
TRPV1 Q8NER1 5/20 0.43
PDE5A O76074 1/20 0.43
ACHE P22303 1/20 0.43
HPGD P15428 1/20 0.43
TNIK Q9UKE5 1/20 0.43
LMNA P02545 2/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3149028 1.00 GAA (0.48) GAAHTTRAB9ACYP2D6CYP2C9
SCHEMBL3156250 0.94 GAA (0.48) GAAHTTRAB9ATNFALDH1A1
SCHEMBL3156243 0.94 GAA (0.48) GAAHTTRAB9ATNFALDH1A1
SCHEMBL8192239 0.93 RAB9A (0.56) GAAHTTRAB9AHIF1ATNF
SCHEMBL8192233 0.93 RAB9A (0.56) GAAHTTRAB9AHIF1ATNF
SCHEMBL30708642 0.93 GAA (0.46) GAAHTTRAB9AHIF1ATNF
SCHEMBL7980994 0.93 GAA (0.48) GAAHTTRAB9ACYP2D6CYP2C9
SCHEMBL17976406 0.93 GAA (0.48) GAAHTTRAB9ACYP2D6CYP2C9
SCHEMBL8176956 0.92 GAA (0.46) GAAHTTRAB9ATNFALDH1A1
SCHEMBL8176952 0.92 GAA (0.46) GAAHTTRAB9ATNFALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224170-B9 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA (DE) 2017-11-22 EP disclosed
WO-2016131789-A1 BENZOPYRROLIDONE DERIVATIVES POSSESSING ANTIVIRAL AND ANTICANCER PROPERTIES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2016-08-25 WO disclosed
EP-3056202-A1 BENZOPYRROLIDONE DERIVATIVES POSSESSING ANTIVIRAL AND ANTICANCER PROPERTIES Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2016-08-17 EP disclosed
EP-2157081-A1 Indolinones substituted in six locations, their manufacture and their application as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2010-02-24 EP disclosed
EP-1224170-B1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA (DE) 2009-08-12 EP disclosed
US-6762180-B1 Substituted indolines which inhibit receptor tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-07-13 US disclosed
EP-1224170-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT Boehringer Ingelheim Pharma KG (DE) 2002-07-24 EP disclosed
WO-2001027081-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-04-19 WO disclosed